A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone aft...
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
About this item
Full title
Author / Creator
Silvennoinen, R , Anttila, P , Säily, M , Lundan, T , Heiskanen, J , Siitonen, T M , Kakko, S , Putkonen, M , Ollikainen, H , Terävä, V , Kutila, A , Launonen, K , Räsänen, A , Sikiö, A , Suominen, M , Bazia, P , Kananen, K , Selander, T , Kuittinen, T , Remes, K and Jantunen, E
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The most common means of mobilizing autologous stem cells is G-CSF alone or combined with cyclophosphamide (CY) to obtain sufficient CD34
+
cells for one to two transplants. There are few prospective, randomized studies investigating mobilization regimens in multiple myeloma (MM), especially after lenalidomide-based induction. We designed thi...
Alternative Titles
Full title
A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4777887
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4777887
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2015.236
